<?xml version="1.0"?>
<Articles JournalTitle="Iranian Journal of Public Health">
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Iranian Journal of Public Health</JournalTitle>
      <Issn>2251-6085</Issn>
      <Volume>38</Volume>
      <Issue>2</Issue>
      <PubDate PubStatus="epublish">
        <Year>2009</Year>
        <Month>06</Month>
        <Day>15</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Evaluation of Antimicrobial Resistance of Acinetobacter baumannii to Imipenem, Ciporofloxacin and Ceftazidime using E Test</title>
    <FirstPage>130</FirstPage>
    <LastPage>133</LastPage>
    <AuthorList>
      <Author>
        <FirstName>MA</FirstName>
        <LastName>Boroumand</LastName>
        <affiliation locale="en_US">Tehran Heart Center, Tehran University of Medical Sciences, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>H</FirstName>
        <LastName>Akhyani</LastName>
        <affiliation locale="en_US">Tehran Heart Center, Tehran University of Medical Sciences, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>M</FirstName>
        <LastName>Sheikhvatan</LastName>
        <affiliation locale="en_US">Tehran Heart Center, Tehran University of Medical Sciences, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>S</FirstName>
        <LastName>Hekmat Yazdi</LastName>
        <affiliation locale="en_US">Reference Laboratories of Iran Research Center, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>R</FirstName>
        <LastName>Saboorian</LastName>
        <affiliation locale="en_US">Reference Laboratories of Iran Research Center, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Sh</FirstName>
        <LastName>Hashemi</LastName>
        <affiliation locale="en_US">Tehran Heart Center, Tehran University of Medical Sciences, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>F</FirstName>
        <LastName>Firouzkouhi</LastName>
        <affiliation locale="en_US">Tehran Heart Center, Tehran University of Medical Sciences, Iran</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2015</Year>
        <Month>10</Month>
        <Day>03</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Background: Resistance patterns among nosocomial bacterial pathogens in hospitals may vary widely from country to coun&#xAD;try at any given point and within the same country over time. Acinetobacter baumannii is one of the most important bacte&#xAD;rium causes hospital acquired infections. Therefore, surveillance of antibiotic resistance of A. baumannii is necessary, espe&#xAD;cially in our country which there is no have much data in this field.
Methods: In a prospective study, strain comprised of a total of 191 recent clinical isolates selected consecutively from clini&#xAD;cal infections of separate patients from three University hospitals in Tehran. Minimum inhibitory concentration (MIC) of these organisms for imipenem, ciprofloxacin and ceftazidime was determined using E test method according to CLSI guide&#xAD;line. Also, MIC50 and MIC90 percent was calculated for each of these antibiotics.
Results: The percentages of Acinetobacter baumannii isolates susceptible to ciprofloxacin and ceftazidime by E test were 55.5% and 44.5%, respectively. The percentage of bacterium susceptible to imipenem by E test was 72.8%. MIC50 and MIC90 of imipenem in E test were 1.5 and &gt;32, respectively.
Conclusion: High antimicrobial resistance against A. baumannii species has been seen in Iran; therefore, it is necessary to imple&#xAD;ment some approaches for prevention of bacterial spread.</abstract>
    <web_url>https://ijph.tums.ac.ir/index.php/ijph/article/view/3199</web_url>
    <pdf_url>https://ijph.tums.ac.ir/index.php/ijph/article/download/3199/2998</pdf_url>
  </Article>
</Articles>
